← All organizations
Highest phase reached
Phase 4
First clinical trial
May 19, 2018Last known activity
Sep 15, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (29 distinct, 11 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (14 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Indications
Studied for
Recent trials (11)
- NCT07088757CollaboratorPhase 4Sep 15, 2025
- NCT07078500CollaboratorPhase 2May 5, 2025
- NCT07022223CollaboratorPhase 2Mar 11, 2025
- NCT06699459CollaboratorPhase 2Nov 14, 2024
- NCT06520163CollaboratorPhase 3Aug 31, 2024
- NCT06520176CollaboratorPhase 3Aug 31, 2024
- NCT05722405CollaboratorPhase 4Jul 1, 2022
- NCT05606107CollaboratorPhase 4May 20, 2022
- NCT05007587CollaboratorEarly Phase 1Jul 1, 2021
- NCT04879615CollaboratorPhase 3Jun 21, 2021
- NCT03520439CollaboratorPhase 2/Phase 3May 19, 2018
Details
- Last known activity
- Sep 15, 2025